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Abstract
Objectives: Deficiency in vitamin D (Vit D) is usually associated with elderly patients. 
This chapter investigates its prevalence amongst the elderly in long-term care in Qatar.
Methodology: The research material included patient chart reviews, electronic data 
and other evidence-based research papers collated between April 2010 and April 2012. 
Geriatric patients 65 years and above in healthcare facilities in Qatar were considered 
as the sample group in this study; its results were analysed and compared, in order of 
diagnosed Vit D deficiency severity.
Results: The total number of patients studied was 889; 66% were female and 34% male, 
with an average age of 75 ± 8.7 years. The Vit D serum level mean baseline utilized was 
24.4 ± 13.5 ng/ml; 72% of patients had Vit D deficiency with 31 and 30% being mildly and 
moderately deficient, respectively, while approximately 11% were severely deficient. A 
positive link was identified between HDL-C and Vit D levels r < 0.17, P < 0.001; however, 
HbA1c levels showed a negative link with Vit D r < 0.15, P < 0.009.
Conclusions: Vit D deficiency was found to be substantially high (72%) among the 
elderly in Qatar. This low level of Vit D was associated with higher HbA1c and lower 
HDL-C levels.
Keywords: elderly, institutionalized patients, geriatrics, vitamin D deficiency, 
comorbidities
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1. Introduction
Vitamin D (Vit D) plays an important role in normal physiological function and is essential 
for bone mineralization [1]. Recently, Vit D deficiency is under consideration due to the fact 
that it has been associated with cardiovascular disorders, malignancy, fractures and deaths 
[2–4]. Vit D deficiency represents an important public health concern which is commonly 
observed worldwide [5–7]. Vit D deficiency remains an underrecognized problem in the 
general  populace and is poorly defined in elderly patients. This phenomenon results from 
reduced capacity of the skin to produce vitamin D, low skin exposure, skin pigmentation, 
sunscreen use, skin covering clothes and a diet low in fish and dairy products. In the elderly 
the reduced dermal synthesis of vitamin D is unlikely to be compensated by dietary intake 
of vitamin D.
In a geriatric population, Vit D deficiency has been associated with poor muscular, physical 
and cognitive physical performance as well as falls and fractures [8]. In a study of com-
munity dwelling persons, performed in the Chianti area in the centre of Italy which has 
a mild pleasant climate and sunlit rural areas, Vit D deficiency was found to be signifi-
cantly high. Vitamin D levels (VDL) noticeably lessens with age in both males and females 
alike, but then the decline starts substantiality earlier and is sharper in females starting 
from the  perimenopausal age. In males the decline in vitamin D levels becomes apparent 
20 years later starting from their 70s, Vit D deficiency is significantly associated with aging 
and elderly patients who need hospitalization for longer periods and as a result more sus-
ceptible [9, 10].
Advanced age and low exposure to sunlight are the major factors associated with Vit D defi-
ciency. Van der Wielen et al. [11] found that regardless of geographical location, free-living 
elderly (>70 years) living in 11 European countries are at substantial risk of inadequate Vit D 
status during winter and spring time and in the oldest and more obese subjects. In fact, 86% 
of these subjects with multiple risk factors were vitamin D deficient. Several studies have 
reported Vit D deficiency among different populations from the Middle East [12–15].
A report from Kuwait showed subclinical Vit D deficiency among veiled women [16]. Also, 
reports from Saudi Arabia demonstrated higher Vit D deficiency in Saudi women. The 
authors found female gender, sedentary lifestyle and low milk consumption to be indepen-
dently associated with lower Vit D levels [17].
In a previous study from Qatar, El-Menyar et al. reported a high percentage (91%) of low 
Vit D level (<30 ng/ml) in adults (mean age: 49 ±12 years); they also found a strong association 
between low Vit D and hypertension [14]. Several studies addressed the association between 
low Vit D and high triglyceride (TG) levels, low levels of high density lipoprotein (HDL-C) 
and the quality of HDL [18]. Furthermore, the interference of ‘Vit D’ in cholesterol synthesis 
and potential synergistic action with statins has been reported [18].
Vit D also plays a role in insulin secretion and therefore is associated with type 2 diabetes mel-
litus (T2DM). Earlier studies suggested a significantly higher risk of T2DM in Vit D–deficient 
patients [19, 20]. In contrast, Hidayat et al. [21] observed no significant association between 
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the incidence of T2DM and Vit D deficiency in an older population. Vit D insufficiency is fre-
quently associated with abnormal bone metabolism including secondary hyperparathyroid-
ism which leads to increase in bone turn over and bone loss particularly cortical bone. Patients 
with chronic kidney disease (CKD) have an exceptionally high rate of Vit D deficiency that 
is further exacerbated by their reduced ability to convert 25-(OH) Vit D into the active form: 
1,25 dihydroxy-Vit D [22]. There are no studies in the elderly population in the Gulf region. 
Therefore, the present study was designed to assess the prevalence of Vit D deficiency and the 
associated risk factors among the geriatric population in Qatar.
2. Patients and methods
2.1. Significance for public health
Low vitamin D levels have been associated with causing a range of chronic conditions. 
A few studies have evaluated the prevalence of low vitamin D prominence in Middle Eastern 
countries like Qatar and its possible correlation with other causes of chronic disease.
Information available recognizes the high prevalence of vitamin D deficiency in Qatar 
and highlights the need to develop a nationwide illustrative study to evaluate further. 
Subsequently, the study may assist in the development of public health strategies for the 
prevention of diseases in Qatar.
2.2. Study setting
This study was conducted between April 2010 and April 2012 and involved data collected 
from elderly patients (65 years). Geriatric patients 65 years and above in healthcare facilities 
in Qatar were considered as the sample group; serum total 25-hydroxyvitamin D (25(OH)
D) levels were measured, individual patient characteristics, treatment plans, treatment and 
results were analysed and compared in order of diagnosed Vit D deficiency severity. Patients 
who had not been screened for Vit D levels or who had incomplete data were excluded.
2.3. Measures
A data-extraction tool was developed that built in information relating to demographics, body 
mass index (BMI, calculated based on height and weight; kg/m2) and blood  examinations 
(full blood count, serum albumin, calcium, phosphorus, comorbidities, medications, and 
outcome).
An immunoanalyser (Liaison, Diasorin Inc.) was used for the measurement of Vit D. ‘It is 
an automated direct competitive chemiluminescence immunoassay (CLIA) for quantitative 
determination of total 25-OH Vit D in serum or plasma. The imprecision at 56 and 19 ng/ml as 
measured by coefficient of variation was 8.7 and 13.2%, respectively [14]’.
The Diazyme’s 25(OH) D assay is one of the fast track diagnostic methods with complete test-
ing results in less than 2 hours. ‘The test is user-friendly, and can be performed manually or 
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easily adapted for use on a wide range of fully automated microtiter plate readers, making it 
suitable for use in laboratories of all sizes and with all manner of testing needs’.
Vit D deficiency was defined as level less than 30 ng/ml which was further subdivided into 
mild (20–29 ng/ml), moderate (10–19 ng/ml) and severe insufficiency (less than 10 ng/ml) [14, 
21]. Patient characteristics and outcomes were analysed and compared according to the sever-
ity of Vit D deficiency. Patients after 6 months were re-evaluated for Vit D levels and all-cause 
mortality.
2.4. Statistical analysis
Where appropriate, data is presented as proportions, medians or mean ±SD. Wherever 
 applicable the continuous variables were analysed using Student’s tests or one-way ANOVA. 
Also a non-parametric Mann–Whitney test was used for skewed continuous data. Definite 
variables among groups were compared using the chi-square test; estimating the associa-
tions between Vit D deficiency and demographic and clinical index. Age and its  correlation 
with HDL-C, HbA1c and Vitamin D levels was also studied using Pearson’s correlation 
method.
A two adjusted P < 0.05 was considered significant. All data investigation was carried out 
using the Statistical Package for Social Sciences version 18 (SPSS Inc., USA).
3. Results
The total number of patients studied was 889; 66% were female of which 77% were Qataris 
and 34% male, with the mean age of between 75 ± 8.7 years. The upper range of age limit 
among the study group was 107 years old male (see Tables 1–3 below for results). Sixty per 
cent of the patients were recruited from Home Healthcare Services (HHS) followed by the 
out-patient (31.8%) and in-patient (7.2%) departments. Findings identified in terms of per-
centages were included; 24.4% had stroke (cerebrovascular accident) and 23.65% had coro-
nary artery disease, respectively, 26.25% had dementia, 76.5% had hypertension, 63.2 % had 
type 2 diabetes and 47.5% dyslipidemia (see Table 1).
The Vit D serum level mean baseline utilized was, 24.4 ±13.5 ng/ml; 72% of patients had Vit 
D deficiency with 31.4 and 29.6% being mildly and moderately deficient, respectively, while 
10.8% were severely deficient (see Table 1).
As a result, 33.5% of patients were prescribed oral supplementation of Vit D. When tested at 
the follow-up 6 months later, Vit D levels available in 325 of these patients had increased to 
28.5 ± 13.4 (P < 0.001).
Table 2 discusses the rate of recurrence and association of sociodemographic and clinical 
variables due to Vit D levels.
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Vit D deficiency was common in females than males, mildly affected patients female to 
male percentage was 70.3 vs. 29.7%, moderate 68.5 vs. 31.5% and severe 70 vs. 30%, P < 0.91; 
though, this was not significant. Patients admitted to HHS had notably more Vit D deficiency 
than other admitting services; mildly affected patients female to male percentage was 54.2 vs. 
45.8%, moderate 68.0 vs. 32% and severe 87.5 vs. 15%, P < 0.001.
Age (years)* 74.9 ± 8.7 Overall vitamin D levels* 24.4 ± 13.5
Female 589 (66.3%) Optimal 175 (28.2%)
Unit Mild deficiency 195 (31.4%)
Home care 421 (59.3%) Moderate deficiency 184 (29.6%)
Out patient 283 (31.8%) Severe deficiency 67 (10.8%)
In-patient 64 (7.2%) Medication
Nationality Multi vitamin 147 (16.5%)
Qatari 655 (76.6%) Proton pump inhibitors 304 (34.2%)
Non-Qatari 200 (23.4%) Vitamin D 50000 IU (orally) 298 (33.5%)
Marital status Calcium supplement 79 (8.9%)
Married 473 (60.1%) Combined fosamax + Vit D 7 (0.8%)
Non-married 314 (39.9%) Calcium + vitamin D 2 (0.2%)
Diagnosis Baseline
Hypertension 680 (76.5%) Vitamin-D (ng/ml)* 24.4 ± 13.5
Diabetes mellitus (Type II) 562 (63.2%) Calcium (mmol/L)* 2.3 ± 0.14
Dyslipidaemia 422 (47.5%) Phosphorus (mmol/L)* 1.17 ± 0.29
Cerebrovascular accident 217 (24.4%) Parathyroid hormone (pmol/L)** 65 (4-625)
Dementia 233 (26.2%) Follow-up
Coronary artery disease 210 (23.6%) Vitamin-D (ng/ml)* 28.5 ± 13.4
Hypothyroidism 110 (12.4%) Calcium (mmol/L)* 2.28 ± 0.2
Heart failure 37 (4.2%) Phosphorus (mmol/L)* 1.19 ± 0.3
Renal dysfunction 99 (11.1%) Parathyroid hormone (pmol/L)** 85 (4-848)
Fracture 32 (3.6%) Mortality 11 (1.2%)
Traumatic injury 21 (2.4%)
Aspiration pneumonia 24 (2.7%)
Urinary tract infection 12 (1.3%)
*Mean ± SD.
**Median (range).
Table 1. Demographics, clinical presentation and outcome in geriatric patients (n = 889).
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Vitamin D deficiency P
Optimal VDL  
(n = 175)
Mild (n = 195) Moderate (n = 184) Severe (n = 67)
Gender
Female 126 (72.0%) 137 (70.3%) 126 (68.5%) 47 (70%) 0.912
Male 49 (28%) 58 (29.7%) 58 (31.5%) 20 (30%)
Unit
HHS 66 (42.0%) 91 (54.2%) 102 (68.0%) 49 (87.5%) 0.001
Out patient 67 (42.7%) 55 (32.7%) 34 (22.7%) 5 (9.4%)
In-patient 24 (15.3%) 22 (13.1%) 14 (9.3%) 2 (3.6%)
Nationality
Qatari 135 (79.4%) 146 (77.2%) 133 (75.6%) 49 (76.6%) 0.354
Non-qatari 35 (20.6%) 43 (22.8%) 43 (24.4%) 15 (23.4%)
Marital status
Married 104 (69.8%) 88 (52.0%) 89 (54.0%) 28 (43.8%) 0.008
Non-married 45 (30.2%) 81 (48.0%) 76 (46.0%) 36 (56.2%)
Diagnosis 
(on-admission)
Diabetes mellitus 107 (61.1%) 128 (65.6%) 124 (67.4%) 46 (68.7%) 0.566
Hypertension 135 (77.1%) 159 (81.5%) 148 (80.4%) 47 (70.1%) 0.217
Dementia 43 (24.6%) 60 (30.8%) 44 (23.9%) 16 (23.9%) 0.388
Coronary artery 
disease
37 (21.1%) 36 (18.6%) 49 (26.6%) 22 (32.8%) 0.055
Heart failure 7 (4.0%) 7 (3.6%) 11 (6.0%) 3 (4.5%) 0.703
Dyslipidaemia 85 (48.6%) 97 (49.7%) 95 (51.6%) 31 (46.3%) 0.879
Renal 
dysfunction
24 (13.7%) 15 (2.4%) 31 (5%) 10 (1.6%) 0.055
Cerebrovascular 
accident
46 (26.3%) 50 (25.6%) 47 (25.5%) 18 (26.9%) 0.996
Hypothyroidism 26 (14.9%) 33 (16.98%) 25 (13.6%) 11 (16.4%) 0.824
Fracture 6 (1%) 5 (7.7%) 9 (16.8%) 5 (14.9%) 0.302
Traumatic 2 (1.1%) 3 (1.5%) 9 (4.9%) 2 (3.0%) 0.100
Social admission 1 (0.6%) 2 (1.0%) 2 (1.1%) 3 (4.5%) 0.101
Aspiration 
pneumonia
5 (2.9%) 3 (1.5%) 4 (2.2%) 3 (4.5%) 0.565
Urinary tract 
infection
1 (0.6%) 4 (2.1%) 4 (2.2%) 0 (0.0%) 0.376
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Further it was found that married patients had a considerably higher number of ideal Vit 
D levels. On admission, diagnoses were compared according to Vit D levels. Proton pump 
inhibitors P < 0.038 and oral Vit D supplementation P < 0.003 were prescribed and adminis-
tered more in Vit D–deficient patients (see Table 2).
The mean blood glucose level was noticeably higher in the severe Vit D-deficient group com-
pared to the ideal group 9.5 ± 5 vs. 7.2 ± 3.2 ng/ml, P < 0.005. The mean age was compared 
between the different Vit D–deficient groups, P < 0.462 (see Table 3).
In patients with T2DM and an estimated glomerular filtration rate (eGFR) _30 ml/min/1.73 m2, 
the mean eGFR was 55.3 ± 8.5 ml/min/1.73 m2. Note that 55 (19.9%) of those had kidney dis-
ease outcomes quality initiative CKD stage 1 disease (eGFR _90 ml/min/1.73 m2), 142 (51.4%) 
had stage 2 disease (eGFR 60–89 ml/min/1.73 m2) and 79 (28.6%) had stage 3 disease (eGFR 
30–59 ml/min/1.73 m2). There was no considerable link between eGFR in type 2 DM and Vit 
D levels (P = 0.43). No correlation analysis was conducted between Vit D levels and eGFR in 
nondiabetic patients as the study population was negligible.
Figures 1 and 2 refer to the connection between Vit D deficiency and HDL-C and HbA1c. 
There was a positive link noted however between HDL-C and Vit D levels (r = 0.173, P = 
0.001), whereas HbA1c levels indicated a negative association with Vit D levels (r = 0.152, 
P = 0.009).
Vitamin D deficiency P
Optimal VDL  
(n = 175)
Mild (n = 195) Moderate (n = 184) Severe (n = 67)
Infected bedsore 1 (0.6%) 2 (1.0%) 2 (1.1%) 2 (3.0%) 0.461
Medication
Multi vitamins 34 (19.4%) 41 (21.0%) 25 (13.6%) 15 (22.4%) 0.209
Proton pump 
inhibitors
52 (29.7%) 79 (40.5%) 76 (41.3%) 34 (50.7%) 0.038
Vitamin D 50,000 
IU (Orally)
65 (37.1%) 81 (41.5%) 96 (52.2%) 39 (58.2%) 0.003
Calcium 
supplement
22 (12.6%) 21 (10.8%) 19 (10.3%) 8 (11.9%) 0.910
Fosamax + 
vitamin D
1 (0.6%) 1 (0.5%) 1 (0.5%) 0 (0%) 0.946
Calcium + 
vitamin D
0 (0%) 1 (0.5%) 0 (0%) 1 (1.5%) 0.237
Mortality 2 (1.1%) 1 (0.5%) 1 (0.5%) 0 (0%) 0.755
HHS: Home Healthcare Services.
Table 2. Comparison of qualitative variables according to vitamin D levels (VDL).
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Vitamin D deficiency P
Baseline Optimal VDL  
(n = 175)
Mild (n = 195) Moderate  
(n = 184)
Severe (n = 67)
Age (years) 74 ± 8.4 75.3 ± 8.3 74.8 ± 7.6 75.5 ± 9.8 0.462
Body mass index 24.7 ± 5.7 23.1 ± 5.2 26.7 ± 6.5 27.2 ± 7.4 0.263
Vitamin D (ng/ml) 41.2 ± 11.5 24.6 ± 2.9 14.9 ± 2.9 6.5 ± 1.9 0.001
Calcium (mmol/L) 2.3 ± 0.14 2.28 ± 0.12 2.29 ± 0.15 2.26 ± 0.13 0.307
Cholesterol (mmol/L) 4.3 ± 0.9 4.4 ± 0.96 4.5 ± 1.2 4.5 ± 1 0.464
Triglycerides (mmol/L) 1.28 ± 0.65 1.38 ± 1.1 1.45 ± 0.7 1.53 ± 0.9 0.304
TSH (mIU/L) 2.2 ± 1.6 3.9 ± 8.9 3.8 ± 10.2 7.1 ± 17.8 0.081
ALP (IU/L) 82.4 ± 45.1 89.6 ± 57.8 99.3 ± 63.4 105 ± 84 0.049
Glucose (mmol/L) 7.2 ± 3.2 7.7 ± 3.7 8.2 ± 5.1 9.5 ± 5 0.005
HbA1c (%) 7.05 ± 1.5 7.3 ± 1.4 7.2 ± 1.8 8 ± 1.9 0.034
LDL (mmol/L) 2.5 ± 0.73 2.6 ± 0.8 2.7 ± 1 2.8 ± 0.8 0.133
eGFR (ml/minute) 55.3 ± 8.5 47.9 ± 18.1 56.1 ± 6.7 50 ± 17.3 0.432
T4 (ng/L) 18 ± 17.5 16 ± 6.8 13.6 ± 2 12.9 ± 2.8 0.381
Phosphorus (mmol/L) 1.17 ± 0.2 1.2 ± 0.4 1.15 ± 0.3 1.05 ± 0.27 0.118
Parathormone (pmol/L) 96.8 ± 124.3 108.5 ± 105.3 161 ± 164 130.2 ± 104.7 0.212
Haemoglobin (g/dl) 12.1 ± 1.6 12 ± 1.8 12.1 ± 1.9 12.07 ± 1.7 0.959
HDL-C (mmol/L) 1.4 ± 0.9 1.3 ± 0.3 1.2 ± 0.4 1.1 ± 0.4 0.040
Ejection fraction (%) 51.9 ± 11.4 54.4 ± 5.5 53.4 ± 9.6 52.8 ± 8.2 0.916
Albumin (mmol/L) 38.4 ± 6.1 38.5 ± 4.5 38.2 ± 9.9 36.7 ± 5.2 0.344
Follow-up
Vitamin D (2) (ng/ml) 38.2 ± 15.9 26.9 ± 9.4 25.6 ± 11.5 22.3 ± 13.8 0.001
Parathyroid hormone 
(pmol/L)
104 ± 81.8 122.2 ± 111.4 154.2 ± 171.9 151.7 ± 185.9 0.807
Calcium (mmol/L) 2.28 ± 0.13 2.32 ± 0.37 2.25 ± 0.15 2.27 ± 0.12 0.516
Phosphorus (mmol/L) 1.1 ± 0.25 1.2 ± 0.29 1.2 ± 0.23 1.2 ± 0.26 0.693
TSH: Thyroid stimulating hormone; ALP: Alkaline Phosphatase; LDL-C: low density lipoprotein cholesterol; HDL-C: 
High Density lipoprotein cholesterol; all variable are expressed as mean ± standard deviation; T4: Thyroxin; eGFR: 
estimated glomerular filtration rate.
Table 3. Comparison of quantitative variables according to vitamin D levels (VDL).
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Figure 1. Correlation between HDL-C and vitamin D levels in geriatric patients.
Figure 2. Correlation between type 2 DM patients HbA1c and vitamin D levels in geriatric patients.




It has been suggested that, lifestyle and socio-cultural practices may be related to the high 
Vit D deficiency reported among the young recently in Qatar [25]. However, the relationship 
between Vit D deficiency and its impact on the health of the elderly is still lacking.
Unfortunately, there are no accurate figures for the confident determination of vitamin D 
 deficiency in Qatar due to the geographical and/or demographical nature of studies  conducted 
[41].
However, centred on data gathered from a review of the system, about 90% of the Qatari popu-
lation may be deficient in serum levels of the vitamin. This exclusive study from the region tries 
to address the impact of age, diabetic status and dyslipidaemia on Vit D  deficiency among the 
geriatric population.
This study found the existence of an extraordinary large number of Vit D deficiency (71.8%) 
among the elderly in Qatar, which may be attributed to their limited exposure to sunlight 
as they age, generally due to the inactive lifestyle, clothing, extreme summers and minimal 
outdoor activity that characterises life in Qatar. A similar study in Indonesia found that 78.2% 
Vit D deficiency was present amongst its elderly population [21].
What is more, with increasing age the capacity of the skin to produce Vit D on sunlight expo-
sure also decreases [23]. Likewise, advanced age reduces Vit D (1,25(OH)2D) production by 
the kidneys [24]. Accordingly, physiological changes and climate conditions together with 
advanced age influence Vit D metabolism among the elderly [25]. In the elderly, Vit D defi-
ciency is associated with an increased risk of falls, osteoporosis and fractures [26]. At present, 
investigation of plasma 25(OH)D is considered as a reliable marker for Vit D level assessment 
[27, 28, 43].
In our study, considerably more patients from the home-based run services had a Vit D 
 insufficiency as well as severe Vit D deficiency in comparison to the in- and out-patient depart-
ments of hospitals (P = 0.001). This corroborates reports from western researchers that found 
a higher occurrence of Vit D insufficiency among communal living elderly [25]. However, in 
the U.S., Vit D insufficiency was incidentally lower in the elderly except in those patients who 
sustained hip fracture [25]. Lund et al. [29] found Vit D deficiency in 25% of hip fracture cases, 
of which 5% had severe Vit D deficiency. However, the incidence of hip fractures in our study 
(14.9%) was relatively lower compared with earlier studies [29].
The present study observed severe Vit D deficiency in 70% of elderly females. Even though 
the Qatar demographics showed that the sex ratio for male:female is 1.7:1. The majority of 
population assigned for this study is female patients; this was decided up on the willingness 
of participation. Other possible explanation for this might be due to the higher life expectancy 
in females [21]. Also, Indonesia reported a higher incidence of Vit D deficiency among its 
elderly females in comparison to elderly males. This high number of women with Vit D defi-
ciency in the Middle East and Asia may be attributed to socio-cultural practices such as the 
use of the veil outside in the Sun.
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Aging has been associated with T2DM [30]. Moreover, several epidemiological studies have 
found a negative correlation between T2DM, obesity and Vit D deficiency [31–33]. Mathieu et 
al. advocated Vit D supplementation for improving glucose tolerance in patients with Vit D 
deficiency [34]. Further, Hidayat et al. [21] reported that in overweight elderly patients, their 
high BMI was pointedly associated with an increased Vit D deficiency.
Our findings previously published online [35] confirm these earlier reports on the link between 
type 2 diabetes (T2DM), body mass index and Vit D deficiency. In this study,  markers of 
T2DM (raised HbA1c and high fasting blood glucose levels) had a negative association with 
levels of circulating vitamin D3. It was observed that significantly high levels of blood glucose 
(P < 0.005) and HbA1c (P < 0.03) were associated with acute Vit D deficiency. Pittas et al. [36] 
in a double-blind, randomized, controlled trial reported that in healthy adults with impaired 
fasting blood glucose, supplementation with vitamin D may attenuate increases in glycaemia 
and insulin resistance that occur over time.
In addition, well documented also has been the association between low Vit D levels and 
chronic kidney disease (CKD). Previous research has shown that in a large majority of 
patients with advanced CKD (stage 2), their levels of Vit D have a tendency to be lower than 
the normal limit, although in patients with advanced CKD (stage 3 and 4), Vit D levels fell 
significantly [37, 38]. Furthermore, elderly patients (<65 years) are likely to have an increased 
association of Vit D deficiency and renal dysfunction with lower glomerular filtration rate 
(GFR) [39].
The present study showed that eGFR was not associated with Vit D levels. Our findings are 
consistent with an earlier study showing no association between an impaired eGFR and Vit 
D deficiency (P < 0.432) [40]. Fraser et al. [41] explored the role of serum 25(OH)D, para-
thyroid hormone and calcium in the development of cardiovascular sicknesses. A positive 
association was identified between HDL-C and 25(OH) D levels; considerably lower HDL-C 
levels were detected in patients with acute Vit D deficiency, consistent with the findings of 
Fraser et al. [41]. As a result, HDL-C levels and Vit D deficiency had a substantial opposite 
relationship, as patients with lower levels of HDL-C had acute Vit D deficiency. LDL-C and 
triglyceride were less in patients with acute Vit D deficiency in comparison to those with 
ideal levels [42].
New research has found in recent times that the presence of vitamin D receptors and the vita-
min D activating enzyme (1-hydroxylase) in the brain has advised a possible role of vitamin 
D in cognitive function. It is suggested that the vitamin D receptor and catalytic enzymes 
are confined to a small area of the brain involved in complex planning, processing and the 
creation of new memories. These findings in theory link the role of vitamin D to cognitive 
impairment, depression and also multiple sclerosis. Although, the current findings cannot be 
supported as dementia is associated with severely low Vit D levels.
Epidemiological research recently has underlined the significance of Vit D and calcium 
supplementation for communal living, hospitalized and care home elderly. The vitamin D 
requirements may vary only based on customary calcium intake. The therapeutic potential 
of vitamin D will not be affected by age and sex difference but may be affected by ethnicity 
[44, 45].
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Taking into consideration the socio-cultural and hereditary factors predominant in the Middle 
East, the proper controlling of Vit D deficiency together with metabolic disorders should be 
made an essential part of treatment for the ageing people. Additionally, the eluding of Vit D 
deficiency among the elderly may possibly be useful for the optimum managing of high-risk 
metabolic disorders such as diabetes mellitus and dyslipidaemia which in time will improve 
the care provided for the population.
This study exposed certain limitations, such as the lack of cause-specific mortality data, as 
well as details of Vit D supplementation. Another limitation was that the influence of sea-
sons and Vit D deficiency was not considered in the analysis; as the study was retrospective 
in nature. Even though these limitations exist, the large sample size is representative of the 
geriatric population in the Middle East. Therefore, this study gives an understanding into the 
occurrence of Vit D deficiency and its attendant issues among the elderly in Qatar.
In conclusion, vitamin D as a nutrient performs several functions, fundamental to the bio-
logical system of the human body including the endocrine and metabolic systems. A large 
occurrence of Vit D deficiency was detected in the elderly. Vit D serum levels were lower, 
the wrong way round with HbA1c and HDL-C levels. The follow-up indicated a small but 
major improvement in Vit D levels after Vit D supplements had been administered. For that 
reason, further research is required to assess whether or not administering Vit D supplements 
improves low HDL-C levels and/or glycemic control in T2DM.
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